Localisation of parathyroid glands using planar 99mTc-sestamibi scintigraphy: Comparison between subtraction- and dual-phase technique;Lokalisation von nebenschild-drüsenadenomen mit planarer 99mTc-sestamibi-szintigraphie: Vergleich von subtraktions-und 2-phasen-technik

NuklearMedizin

Volumn 45, Issue 3, 2006, Pages 115-121

  Schommartz, B ^a,b   Cupisti, K ^a   Antke, C ^a   Schmidt, D ^a   Knoefel, W T ^a   Muller H W ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Dual phase technique; Primary hyperparathyreoidism; Sestamibi scintigraphy; Subtraction technique

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARATHYROID ADENOMA; PARATHYROID GLAND; PREDICTION; PRIMARY HYPERPARATHYROIDISM; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; STUDENT T TEST; SURGICAL TECHNIQUE; HYPERPARATHYROIDISM; METHODOLOGY; SCINTISCANNING; TREATMENT OUTCOME;

HUMANS; HYPERPARATHYROIDISM; PARATHYROID GLANDS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TECHNETIUM TC 99M SESTAMIBI; TREATMENT OUTCOME;

EID: 33745885647     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1625329     Document Type: Article

References (24)

1. Arveschoug AK, Bertelsen H, Vammen B. Presurgical localization of abnormal parathyroid glands using a single injection of 99mTc sestamibi: comparison of high-resolution parallel-hole and pin-hole collimators, and interobserver and intraobserver variation. Clin Nucl Med 2002; 27: 249-54.
2. Bekis R, Aydin A, Tasci C et al. The role of gamma probe activity counts in minimally invasive parathyroidectomy. Preliminary results. Nuklearmedizin 2004; 43: 190-4.
3. Berczi C, Mezosi E, Galuska L et al. Technetium-99m-sestamibi/ pertechnetate subtraction scintigraphy vs ultrasonography for preoperative localization in primary hyperparathyroidism. Eur Radiol 2002; 12: 605-9.
4. Chen CC, Holder LE, Scovill WA et al. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT. J Nucl Med 1997; 38: 834-9.
5. Chen EM, Mishkin FS. Parathyroid hyperplasia may be missed by double-phase Tc-99m sestamibi scintigraphy alone. Clin Nucl Med 1997; 22: 222-6.
6. Coakley AJ, Kettle AG, Wells CP et al. 99mTc sestamibi - a new agent for parathyroid imaging. Nucl Med Commun 1989; 10: 79-4.
7. Fahy BN, Bold RJ, Beckett L et al. Modern parathyroid surgery: a cost-benefit analysis of localizing strategies. Arch Surg 2002; 137: 917-22.
8. Gagner M. Endoscopic subtotal parathyroidectomy in patients with primary hyperparathyroidism. Br J Surg 1996; 83: 875
9. Gotthardt M, Lohmann B, Behr TM et al. Clinical value of parathyroid scintigraphy with technetium-99m methoxyisobutylisonitrile: discrepancies in clinical data and a systematic metaanalysis of the literature. World J Surg 2004; 28: 100-7.
10. Gotway MB, Reddy GP, Webb WR et al. Comparison between MR imaging and 99mTc MIBI scintigraphy in the evaluation of recurrent of persistent hyperparathyroidism. Radiology 2001; 218: 783-90.
11. Haber RS, Kim CK, Inabnet WB. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy, Clin Endocrinol (Oxf) 2002; 57: 241-9.
12. Henry JF, Iacobone M, Mirallie E et al. Indications and results of video-assisted parathyroidectomy by a lateral approach in patients with primary hyperparathyroidism. Surgery 2001; 130: 999-1004.
13. Kaczirek K, Prager G, Kienast O et al. Combined transmission and (99m)Tc-sestamibi emission tomography for localization of mediastinal parathyroid glands. Nuklearmedizin 2003; 42: 220-3.
14. Leslie WD, Dupont JO, Bybel B et al. Parathyroid 99mTc-sestamibi scintigraphy: dual-tracer subtraction is superior to double-phase washout. Eur J Nuci Med 2002; 29: 1566-70.
15. Leslie WD, Riese KT, Dupont JO et al. Parathyroid adenomas without sestamibi retention. Clin Nucl Med 1995; 20: 699-702.
16. Miccoli P, Monchik JM. Minimally invasive parathyroid surgery. Surg Endosc 2000; 14: 987-90.
17. 99m-Tc-MIBI SPECT parathyroid gland scintigraphy for the preoperative localization of small parathyroid gland adenomas. Nuklearmedizin 1997; 36: 240-4.
18. 99mTc-Subtraktionsszintigraphie im Vergleich zur 5-MHz-Sonographie. Fortschr Röntgenstr 1985; 142: 543-7.
19. 99mTc-sestamibi subtraction SPECT in hyperparathyroidism. Am J Roentgenol 1997; 169: 1671-A
20. Nilsson B, Fjalling M, Klingenstierna H et al. Effects of preoperative parathyroid localisation studies on the cost of operations for persistent hyperparathyroidism. Eur J Surg 2001; 167: 587-91.
21. Rubello D, Saladini G, Casara D et al. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique. Clin Nucl Med 2000; 25: 527-31.
22. Ruf J, Lopez Hanninen E, Steinmuller T et al. Preoperative localization of parathyroid glands. Use of MRl, scintigraphy, and image fusion. Nuklear-medizin 2004; 43: 85-90.
23. Taillefer R, Boucher Y, Potvin C et al. Detection and localization of parathyroid adenomas in patients with hyperparathyroidism using a single radionuclide imaging procedure with technetium-99m-sestamibi (double-phase study). J Nucl Med 1992; 33: 1801-7.
24. 99mTc-sestamibi radionuclide scans. Ann Surg 1994; 219: 568-72.